Huapont Life Sciences Co Ltd

SHE:002004 China Agricultural Inputs
Market Cap
$1.49 Billion
CN¥10.95 Billion CNY
Market Cap Rank
#7513 Global
#1298 in China
Share Price
CN¥5.53
Change (1 day)
-1.78%
52-Week Range
CN¥3.78 - CN¥5.88
All Time High
CN¥11.08
Categories
Companies in China Agricultural Inputs
About

Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more

Huapont Life Sciences Co Ltd (002004) - Net Assets

Latest net assets as of September 2025: CN¥16.10 Billion CNY

Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) has net assets worth CN¥16.10 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥29.24 Billion) and total liabilities (CN¥13.15 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥16.10 Billion
% of Total Assets 55.05%
Annual Growth Rate 25.23%
5-Year Change 9.46%
10-Year Change 48.63%
Growth Volatility 45.15

Huapont Life Sciences Co Ltd - Net Assets Trend (2001–2024)

This chart illustrates how Huapont Life Sciences Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Huapont Life Sciences Co Ltd (2001–2024)

The table below shows the annual net assets of Huapont Life Sciences Co Ltd from 2001 to 2024.

Year Net Assets Change
2024-12-31 CN¥15.47 Billion -6.70%
2023-12-31 CN¥16.58 Billion +0.21%
2022-12-31 CN¥16.55 Billion +4.59%
2021-12-31 CN¥15.82 Billion +11.93%
2020-12-31 CN¥14.14 Billion +6.74%
2019-12-31 CN¥13.24 Billion +3.88%
2018-12-31 CN¥12.75 Billion -4.12%
2017-12-31 CN¥13.30 Billion +24.22%
2016-12-31 CN¥10.70 Billion +2.82%
2015-12-31 CN¥10.41 Billion +81.62%
2014-12-31 CN¥5.73 Billion +42.86%
2013-12-31 CN¥4.01 Billion +35.69%
2012-12-31 CN¥2.96 Billion +14.35%
2011-12-31 CN¥2.59 Billion +149.66%
2010-12-31 CN¥1.04 Billion +15.43%
2009-12-31 CN¥897.32 Million +10.23%
2008-12-31 CN¥814.07 Million +11.38%
2007-12-31 CN¥730.86 Million +39.77%
2006-12-31 CN¥522.90 Million +18.66%
2005-12-31 CN¥440.68 Million +9.72%
2004-12-31 CN¥401.64 Million +175.58%
2003-12-31 CN¥145.74 Million +42.64%
2002-12-31 CN¥102.18 Million +16.80%
2001-12-31 CN¥87.48 Million --

Equity Component Analysis

This analysis shows how different components contribute to Huapont Life Sciences Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 8652.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥1.60 Billion 17.11%
Common Stock CN¥1.98 Billion 21.20%
Other Comprehensive Income CN¥1.01 Billion 10.82%
Other Components CN¥4.75 Billion 50.87%
Total Equity CN¥9.34 Billion 100.00%

Huapont Life Sciences Co Ltd Competitors by Market Cap

The table below lists competitors of Huapont Life Sciences Co Ltd ranked by their market capitalization.

Company Market Cap
Staidson Beijing Biopharma
SHE:300204
 		$955.18 Million
Mercialys
PINK:MEIYF
 		$955.20 Million
CRISIL Limited
NSE:CRISIL
 		$955.46 Million
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
 		$955.67 Million
MY EG Services Bhd
KLSE:0138
 		$954.57 Million
Ninety One Group
PINK:NINTF
 		$954.35 Million
Guodian Nanjing Automation Co Ltd
SHG:600268
 		$954.10 Million
Hong Leong Financial Group Bhd
KLSE:1082
 		$954.09 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Huapont Life Sciences Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 10,105,176,600 to 9,337,058,000, a change of -768,118,600 (-7.6%).
  • Net loss of 298,989,912 reduced equity.
  • Dividend payments of 754,366,728 reduced retained earnings.
  • Other comprehensive income increased equity by 1,009,823,000.
  • Other factors decreased equity by 724,584,960.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥-298.99 Million -3.2%
Dividends Paid CN¥754.37 Million -8.08%
Other Comprehensive Income CN¥1.01 Billion +10.82%
Other Changes CN¥-724.58 Million -7.76%
Total Change CN¥- -7.60%

Book Value vs Market Value Analysis

This analysis compares Huapont Life Sciences Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.17x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 62.74x to 1.17x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2001-12-31 CN¥0.09 CN¥5.53 x
2002-12-31 CN¥0.10 CN¥5.53 x
2003-12-31 CN¥0.15 CN¥5.53 x
2004-12-31 CN¥0.38 CN¥5.53 x
2005-12-31 CN¥0.43 CN¥5.53 x
2006-12-31 CN¥0.46 CN¥5.53 x
2007-12-31 CN¥0.67 CN¥5.53 x
2008-12-31 CN¥0.76 CN¥5.53 x
2009-12-31 CN¥0.85 CN¥5.53 x
2010-12-31 CN¥0.99 CN¥5.53 x
2011-12-31 CN¥2.41 CN¥5.53 x
2012-12-31 CN¥2.13 CN¥5.53 x
2013-12-31 CN¥2.66 CN¥5.53 x
2014-12-31 CN¥3.51 CN¥5.53 x
2015-12-31 CN¥5.09 CN¥5.53 x
2016-12-31 CN¥4.76 CN¥5.53 x
2017-12-31 CN¥4.69 CN¥5.53 x
2018-12-31 CN¥4.47 CN¥5.53 x
2019-12-31 CN¥4.67 CN¥5.53 x
2020-12-31 CN¥4.86 CN¥5.53 x
2021-12-31 CN¥5.11 CN¥5.53 x
2022-12-31 CN¥5.15 CN¥5.53 x
2023-12-31 CN¥5.10 CN¥5.53 x
2024-12-31 CN¥4.73 CN¥5.53 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Huapont Life Sciences Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.20%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2.56%
  • • Asset Turnover: 0.40x
  • • Equity Multiplier: 3.15x
  • Recent ROE (-3.20%) is below the historical average (12.46%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 35.56% 17.87% 1.30x 1.52x CN¥22.36 Million
2002 37.05% 18.63% 0.97x 2.06x CN¥27.23 Million
2003 27.61% 16.60% 1.07x 1.56x CN¥25.46 Million
2004 12.59% 17.48% 0.57x 1.27x CN¥9.81 Million
2005 12.18% 19.20% 0.57x 1.11x CN¥9.41 Million
2006 14.23% 22.28% 0.38x 1.70x CN¥19.08 Million
2007 30.83% 41.93% 0.45x 1.63x CN¥139.49 Million
2008 11.79% 15.70% 0.50x 1.51x CN¥13.51 Million
2009 15.24% 23.45% 0.48x 1.36x CN¥43.89 Million
2010 13.54% 24.40% 0.40x 1.39x CN¥34.49 Million
2011 12.76% 48.54% 0.15x 1.75x CN¥65.97 Million
2012 12.39% 8.57% 0.65x 2.21x CN¥64.12 Million
2013 7.97% 6.78% 0.58x 2.01x CN¥-77.04 Million
2014 7.70% 8.82% 0.36x 2.43x CN¥-128.39 Million
2015 6.69% 10.31% 0.31x 2.07x CN¥-315.69 Million
2016 5.88% 7.99% 0.29x 2.51x CN¥-397.66 Million
2017 5.33% 5.51% 0.32x 3.06x CN¥-443.51 Million
2018 5.59% 4.79% 0.40x 2.93x CN¥-400.05 Million
2019 6.64% 6.15% 0.38x 2.85x CN¥-313.87 Million
2020 6.77% 5.99% 0.39x 2.93x CN¥-311.22 Million
2021 6.61% 5.37% 0.41x 2.97x CN¥-343.13 Million
2022 4.25% 3.28% 0.44x 2.95x CN¥-585.71 Million
2023 2.99% 2.61% 0.38x 3.04x CN¥-708.40 Million
2024 -3.20% -2.56% 0.40x 3.15x CN¥-1.23 Billion

Industry Comparison

This section compares Huapont Life Sciences Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.

Industry Context

  • Industry: Agricultural Inputs
  • Average net assets among peers: $1,377,962,235
  • Average return on equity (ROE) among peers: 22.54%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Huapont Life Sciences Co Ltd (002004) CN¥16.10 Billion 35.56% 0.82x $954.57 Million
Nanjing Red Sun Co Ltd (000525) $3.56 Billion 10.45% 1.90x $869.96 Million
ADAMA Ltd (000553) $489.53 Million 15.85% 0.90x $443.23 Million
Grand Industrial Holding Co Ltd (000626) $377.84 Million 8.82% 3.63x $231.55 Million
Sichuan Meifeng Chemical Industry Co Ltd (000731) $1.81 Billion 11.10% 1.14x $499.40 Million
Qinghai Salt Lake Industry Co.Ltd (000792) $422.65 Million 11.02% 0.61x $16.80 Billion
Asia Potash International Investment Guangzhou Co Ltd (000893) $144.66 Million 30.88% 2.19x $4.75 Billion
Hubei Xinyangfeng Fertilizer Co Ltd (000902) $452.01 Million -10.57% 1.67x $1.47 Billion
Sichuan Lutianhua Co Ltd (000912) $6.26 Billion 5.87% 0.66x $848.59 Million
Guangxi Hechi Chemical Co Ltd (000953) $23.30 Million 126.44% 34.10x $229.11 Million
Norsyn Crop Technology Co. Ltd. A (001231) $234.00 Million 15.58% 0.64x $97.83 Million